AI assistant
Aquis Exchange Plc Director's Dealing 2022
6169_dirs_2022-06-23_e6443227-cd65-44eb-8d00-94efa716514b.html
Director's Dealing
Open in viewerOpens in your device viewer
National Storage Mechanism | Additional information 
RNS Number : 8628P
Aquis Exchange PLC
23 June 2022
23 June 2022
Aquis Exchange PLC ("Aquis Exchange")
Director/PDMR Notification
Aquis Exchange PLC makes the following announcement regarding its Directors' participation in the Aquis Share Incentive Plan.
1.
Details of PDMR / person closely associated with them ("PCA")
a)
Name
Richard Fisher
2.
Reason for the notification
b)
Position / status
CFO
c)
Initial notification / amendment
Initial notification
3.
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)
Name
Aquis Exchange PLC
b)
LEI
213800IXJSF5E1SIW150
4.
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)
Description of the financial instrument
Identification Code
Ordinary Shares of 10p each
GB00BD5JNK30
b)
Nature of the transaction
Richard Fisher participated in the Aquis Share Incentive Plan ("SIP"). The SIP is a HMRC approved tax-advantaged all-employee share scheme. Under it, employees are able to purchase ordinary shares at market value using deductions from salary, and receive allocations of matching and free ordinary shares. These ordinary shares are held by the employee benefit trust for the SIP.
c)
Price(s) and volume(s)
| Price(s) | Volume(s) |
| 415p | 1,302 |
d)
Aggregated information
- Aggregated volume
- Price
1,302
415p
e)
Date of the transaction
20 June 2022
f)
Place of the transaction
London Stock Exchange, AIM Market (XLON)
1.
Details of PDMR / person closely associated with them ("PCA")
a)
Name
Jonathan Clelland
2.
Reason for the notification
a)
Position / status
COO
b)
Initial notification / amendment
Initial notification
3.
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)
Name
Aquis Exchange PLC
b)
LEI
213800IXJSF5E1SIW150
4.
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)
Description of the financial instrument
Identification Code
Ordinary Shares of 10p each
GB00BD5JNK30
b)
Nature of the transaction
Jonathan Clelland participated in the Aquis Share Incentive Plan ("SIP"). The SIP is a HMRC approved tax-advantaged all-employee share scheme. Under it, employees are able to purchase ordinary shares at market value using deductions from salary, and receive allocations of matching and free ordinary shares. These ordinary shares are held by the employee benefit trust for the SIP.
c)
Price(s) and volume(s)
| Price(s) | Volume(s) |
| 415p | 1,302 |
d)
Aggregated information
- Aggregated volume
- Price
415p
e)
Date of the transaction
20 June 2022
f)
Place of the transaction
London Stock Exchange, AIM Market (XLON)
Enquiries:
| Aquis Exchange PLC | Tel: +44 (0) 20 3597 6321 |
| Richard Fisher, CFO | |
| VSA Capital Limited (AQSE Corporate Adviser) | Tel: +44(0)20 3005 5000 |
| Andrew Raca | |
| Pascal Wiese | |
| Liberum Capital Limited (Nominated Adviser and Joint Broker) | Tel: +44 (0) 20 3100 2000 |
| Chris Clarke | |
| Clayton Bush | |
| Edward Thomas | |
| Kane Collings | |
| Canaccord Genuity Limited (Joint Broker) | Tel: +44 (0) 20 7523 8000 |
| Bobbie Hilliam | |
| Patrick Dolaghan | |
| Alma PR (Financial PR Adviser) | Tel: +44 (0)20 3405 0209 |
| Susie Hudson | [email protected] |
| Kieran Breheny | |
| Matthew Young |
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
END
NEXFLFIRRIIFFIF